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ABSTRACT 
γ-Aminobutyric acid (GABA) and GABA-rich foods have shown anti-hypertensive and anti-
depressant activities as the major functions in humans and animals. Hence, high GABA-
producing lactic acid bacteria (LAB) could be used as functional starters for manufacturing novel 
fermented dairy foods. Glutamic acid decarboxylases (GADs) from LAB are highly conserved at 
the species level based on the phylogenetic tree of GADs from LAB. Moreover, two functionally 
distinct GADs and one intact gad operon were observed in all the completely sequenced 
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Lactobacillus brevis strains suggesting its common capability to synthesize GABA. Difficulties 
and strategies for the manufacture of GABA-rich fermented dairy foods have been discussed and 
proposed, respectively. In addition, a genetic survey on the sequenced LAB strains demonstrated 
the absence of cell envelope proteinases in the majority of LAB including Lb. brevis, which 
diminishes their cell viabilities in milk environments due to their non-proteolytic nature. Thus, 
several strategies have been proposed to overcome the non-proteolytic nature of Lb. brevis in 
order to produce GABA-rich dairy foods. 
 
Keywords: γ-aminobutyric acid; Lactobacillus brevis; glutamic acid decarboxylase; cell 
envelope proteinase; dairy fermentation; dairy starter culture 
 
INTRODUCTION 
Lactic acid bacteria (LAB) are organisms that produce lactic acid as the dominant end 
product of carbohydrate fermentation and have been extensively used for food fermentation 
(Leroy et al., 2004). These include the core genus of Lactobacillus, Leuconostoc, Pediococcus, 
Lactococcus and Streptococcus, as well as the peripheral Enterococcus, Oenococcus and 
Weisella (Stiles et al., 1997). In LAB, catabolism of carbohydrates is via various pathways such 
as Embden-Meyerhof-Parnas (EMP) pathway, Leloir pathway and pentose phosphate pathway 
for producing lactic acid as the major end metabolite (Kandler, 1983). Lactic acid generated from 
above pathways affects the intracellular metabolic activities via altering the activities of enzymes 
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under such acidic condition in bacterial cytoplasm. Also, exogenous proton enters into the 
bacterial cytoplasm if the condition in the environments is extremely acidic. Hence, in order to 
maintain the viability and cellular activities against the acidic condition, LAB have developed 
several acid resistance including the most common F0F1-ATPase system and cation/proton 
antiporters/symporters, and also including specific urease system, amino acid decarboxylase 
system and amino acid deiminase/deaminase system (Hutkins et al., 1993). Among them, 
glutamic acid decarboxylase (GAD) system in LAB such as Lb. brevis, has been documented 
recently, and serves as a fitness determinant in LAB for acid resistance (De Biase et al., 2012; 
Feehily et al., 2013; Li et al., 2010a; Teixeira et al., 2014). γ-Aminobutyric acid (GABA) is the 
end product of the decarboxylation of glutamic acid in LAB. It has shown several important 
physiological activities in humans and animals (Foster et al., 2006). Moreover, GABA or 
GABA-rich products have been successfully commercialized as food additives or functional food 
supplements, and some high GABA-producing LAB strains have been used to produce 
functional foods containing GABA.  
In this review, the biofunctionalities of GABA and GABA-rich foods, high GABA-
producing LAB including Lb. brevis, and the activities and phylogeny of their glutamic acid 
decarboxylases (GADs) have been discussed. However, the absence of genes encoding cell 
envelope proteinases (hence non-proteolytic in nature) has been found in the genomes of most 
LAB strains including Lb. brevis, these LAB strains may not be able to survive and even ferment 
milk. Hence, several strategies against this shortage have been proposed. Difficulties and 
strategies for manufacturing GABA-rich fermented dairy foods have also been discussed and 
proposed, respectively. 
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BIOFUNCTIONALITIES OF GABA AND GABA-RICH FOODS 
GABA is widely distributed in the animal and plant products. In animals, GABA is the major 
inhibitory neurotransmitter in central nervous system (CNS) (McCormick, 1989), while it also 
has multiple functions such as regulating cytosolic pH, protecting against oxidative stress, acting 
as an osmoregulator and a signalling molecule in plants (Bouche et al., 2004).  Scientific and 
medicinal evidences suggest that GABA cannot cross blood-brain barrier (BBB) because of the 
absence of specific receptors in the human BBB (Kuriyama et al., 1971). However, certain pro-
drugs of GABA after structural modifications, such as nicotinoyl-GABA, are able to permeate 
the BBB and thus exhibit its pharmacological effects in human (Matsuyama et al., 1984).  
Despite the absence of certain receptors in BBB for binding GABA molecule, GABA or 
GABA-rich foods are still able to deliver benefits to the host after oral administration as 
indicated in Table 1. A pioneering study conducted in 2003 reported that daily intake of 
fermented milk containing 10-12 mg/100 mL of GABA could significantly lower blood pressure 
in patients with mild hypertension within 2 weeks (Inoue et al., 2003). In general, anti-
hypertensive and anti-depressant activities are the major functions of GABA or GABA-rich 
foods. However, mechanisms of these activities are still unknown due to fewer studies on the 
pathway for GABA absorption. The proposed mechanism is that GABA may reach certain areas 
of brain such as periventricular nucleus with ineffective or reduced BBB function, thus 
increasing the concentration of GABA in GABAergic synapse of the neurons (Muller et al., 
1999). Moreover, there is very limited information on the effective dosage of GABA for 
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exhibiting anti-hypertensive and anti-depressant activities. Further studies are necessary to 
understand these mechanisms.  
DIVERSITY OF GABA-PRODUCING LACTIC ACID BACTERIA – GENETIC SURVEY 
ON GLUTAMIC ACID DECARBOXYLASE AND EXPERIMENTAL FERMENTATION 
Although GABA is widely found in the natural animal and plant based products, its content 
is very low, hence requiring enrichment process. As a result, products with low GABA level are 
not sufficient to deliver its benefits to human host. Currently, chemically synthesized GABA is 
prohibited as food additive, thus GABA produced by food-grade microorganisms, especially 
LAB, will be of great importance for manufacturing food-grade GABA or GABA-rich foods via 
various fermentations where food-grade substances are used as fermentative substrates.  
Although there are many microorganisms that are capable of producing GABA, the main 
focus of this review is GABA production by LAB due to their food-grade nature and generally 
regarded as safe (GRAS) status. Thus, glutamic acid decarboxylase (GAD) in LAB has been 
searched in NCBI protein database, the phylogenetic tree of LAB GADs has been constructed, 
and are shown in Fig. 1. In general, the amino acid sequences of GADs are highly conserved at 
the species level (Fig. 1A). As indicated in Fig. 1A, it was found that the genes encoding GADs 
were mainly distributed in Lactobacillus brevis, Lb. plantarum, Lb. fermentum, Lb. reuteri, 
Strrptococcus thermophilus, Lactococcus lactis subsp. cremoris, Lc. lactis subsp. lactis and some 
Bifidobacterium species. This genetic evidence indicates that strains in above species with the 
GAD gene in them may be able to synthesize GABA. Some GABA-producing Str. thermophilus 
and Lc. lactis strains may be of great interest to dairy and starter culture industries, which may 
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 H
on
g K
on
g L
ibr
ari
es
] a
t 0
1:4
4 2
6 A
pr
il 2
01
6 
ACCEPTED MANUSCRIPT 
ACCEPTED MANUSCRIPT 6 
generate GABA-rich milk products if these strains were involved in the fermentation process. In 
particular, it was observed that the presence of GAD-encoding genes in both subspecies of Lc. 
lactis (Fig. 1A) did not support the previous finding that the ability of producing GABA could be 
able to distinguish Lc. lactis subsp. lactis from Lc. lactis subsp. cremoris (Nomura et al., 1999a).  
Notably, GAD-encoding gene in various microorganisms can be detected by using 
polymerase chain reaction (PCR) method, which may be able to indicate their capacity to 
produce GABA at genetic level. However, in this review, we only focused on the high GABA 
producers in which their GABA yield has been confirmed. As shown in Table 2, several high 
GABA-producing LAB strains have been isolated from various environments in the last decade. 
It was found that acid-based fermented foods such as Korean kimchi and pickled vegetables 
could be the habitat of high GABA producers. Those high GABA producers could eliminate 
intracellular protons during the decarboxylation of glutamate by GAD to maintain the 
intracellular pH homeostasis under acidic conditions (Hutkins et al., 1993). Since the acid 
fermentation is a natural process, acid-based fermented foods could be an important source for 
the screening of high GABA producer.  
The GABA yield in Table 2 is not comparable because these isolates have been cultivated in 
respective media under certain incubation conditions. However, based on those author’s 
interpretations, these isolates were claimed as being high GABA producers because they 
produced more GABA as compared to other LAB strains. In addition, it has been found that most 
of the high GABA producers belong to Lb. brevis and Lb. plantarum (Table 2). Importantly, 
several important species such as Lc. lactis, Str. thermophilus and Lb. bulgaricus isolated from 
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milk environments also exhibit abilities to produce GABA. This could be used to generate 
GABA-rich fermented milk products. However, to our knowledge, these dairy isolates produced 
less GABA than those of Lb. brevis and Lb. plantarum. Thus, use of Lb. brevis as functional 
starter for dairy fermentation to manufacture GABA-rich cultured dairy foods such as cheese and 
yogurt could be promising. 
METHODS FOR THE MEASUREMENT OF GABA AND FOR THE SCREENING OF 
GABA PRODUCER 
A rapid and accurate analytical method is critical for differentiating the level of GABA 
content in foods and for screening GABA producers. Currently, chromatography-based 
techniques such as amino acid analyzer (AAA), liquid chromatography (LC), gas 
chromatography (GC) and thin layer chromatography (TLC) are still the first choice for 
determining GABA content in various food samples (Li et al., 2010a). AAA and TLC techniques 
do not require the derivatization process for GABA, but TLC method does not provide enough 
accuracy for quantifying GABA; LC method normally requires pre-column derivatization with 
dansyl chloride by an addition of chromophore to GABA that could be detected by fluorescence 
spectroscopy (Wu et al., 2015b); For GC method, pre-column derivatization of GABA is usually 
achieved with norvaline to form a volatile compound, which could be separated and detected by 
GC equipped with a flame ionization detector (FID) or mass spectrometry (MS) (Kagan et al., 
2008). Above methods are time-consuming due to tedious sample preparation processes 
according to analytical protocols; this requires high work-load for screening GABA-producing 
microorganisms, and is not economical nor rapid. Hence, a pre-screening method is necessary for 
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identifying GABA producers prior to determining their capability to produce GABA by 
chromatography-based methods. Many researchers used TLC as a pre-screening method, but this 
requires a number of plates and a large volume of solvents (Li et al., 2010a). Currently, pre-
screening methods are normally developed based on the decarboxylation of glutamate into 
GABA by glutamate decarboxylase; this reaction eliminates a proton and also produces carbon 
dioxide. Thus, glutamate decarboxylase-based microtiter plate assay (Tsukatani et al., 2005), pH 
indicator method (Yang et al., 2006) and gas release-based assays (Wu et al., 2015b) are suitable 
for high-throughput pre-screening of GABA producers with remarkable improvements in testing 
time and economic practice. 
HIGH GABA-PRODUCING LACTOBACILLUS BREVIS 
As shown in Table 2, the high GABA production from Lb. brevis has been confirmed by 
several individual studies on various Lb. brevis strains. In addition to the experimental data, we 
conducted a survey in regards to the presence or absence of gad operons in the sequenced Lb. 
brevis strains at the genomic level. Till 1
st
 November 2015, a total of 14 complete or incomplete 
(at contigs or scaffolds level) genome sequences of Lactobacillus brevis isolated from various 
environments have been released in NCBI database; among them, 13 strains have the intact gad 
operon in their genomes except for Lb. brevis subsp. gravesensis ATCC 27305. It appears that 
Lb. brevis appears to be a common cell factory to produce GABA. Furthermore, we have 
demonstrated that the GAD system is more efficient to eliminate protons than both agmatine 
deiminase (AgDI) system and arginine deiminase (ADI) system in Lb. brevis during late 
stationary growth phase; this is evidenced by the content of end product of above systems 
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(GABA from GAD system, putrescine from AgDI system and ornithine from ADI system) in Lb. 
brevis when incubated in de Man, Rogosa and Sharpe (MRS) broth at 37℃ (unpublished data). 
This implies that GAD system in Lb. brevis is an important and efficient system under acidic 
conditions in Lb. brevis thus producing high content of GABA in the medium. 
Moreover, two GAD-encoding genes – gadA (~ 479 aa) and gadB (~ 468 aa) encoding two 
distinct GADs were found in Lb. brevis (Fig. 1A). Attentions should be paid to the names of two 
GAD-encoding genes in Lb. brevis. Some studies used the same name of gadB for both two 
GAD-encoding genes in Lb. brevis if both genes existed in their genomes. This is confusing to 
differentiate these two GAD-encoding genes in the same organism. In this review, the 
classification of GADs from Lb. brevis is based on one previous comparative study where single 
but a different GAD gene (gadA) in the intact operon has been amplified from high GABA-
producing Lb. brevis NCL912 (Li et al., 2013). In general, the gadA-encoding GAD from Lb. 
brevis shows a distinct relationship with other GADs found in Lb. plantarum, Lc. lactis, Lb. 
reuteri and Lb. fermentum (Fig. 1A), which suggests the occurrence of independent evolution in 
Lb. brevis. Some high GABA producers isolated have been identified as Lb. plantarum (Table 2) 
and the genetic distance of their GADs is close to the gadB-encoding GAD, but not gadA-
encoding GAD from Lb. brevis (Fig. 1A). Moreover, it was observed that only one GAD gene 
(gadA or gadB) was present in the gad operon in Lb. brevis, whereas another GAD gene in Lb. 
brevis (gadB) is far away from the gad operon in their complete genomes (Fig. 1B). Based on the 
information from the phylogenetic tree, it suggests that Lb. brevis may integrate gadB from other 
bacteria into its genome via gain-of-function theory, e.g. horizontal gene transfer (HGT), but not 
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due to the gene duplication theory because the translated amino acids sequences of gadA and 
gadB do not have high score in identity (Fig. 1C).  
Alignment of the amino acids sequences of gadA- and gadB-encoding GADs from two 
representative GABA-producing Lb. brevis strains (IFO 12005 and 877G) is shown Fig. 1C. It 
was found that gadA (Lb. brevis IFO 12005) and gadB (Lb. brevis 877G) show only ~ 50% 
identity in amino acids sequences, however, the PLP-binding domain where the active site 
residues (D, H & K; Fig. 1C) of both GADs are highly conserved. This suggests that both GADs 
from Lb. brevis may show the core function. 
ENZYMATIC ACTIVITIES OF LAB GLUTAMIC ACID DECARBOXYLASES 
Several important studies have shown the activities of hetero-expressed GADs from several 
species as exhibited in Table 3. It was observed that these GADs have different optimal 
conditions and activities. In general, the pH between 4.0 ~ 5.0 is preferred for exhibiting their 
optimal activities. The GADs from Lb. paracasei NFRI7415, Str. thermophilus Y2, Lb. brevis 
CGMCC 1306 and Lb. brevis 877G exhibited highest activities at a temperature over 45℃, 
which is not an optimal condition for bacterial growth. Thus, these GABA producers incubated 
at normal temperature (37℃) may have an effect on their GABA biosynthesis. 
In addition, the gadB-encoding GAD from Lb. brevis 877G had a lower Km than gadA-
encoding GADs from Lb. brevis CGMCC 1306 and Lb. brevis IFO 12005 under their optimal 
conditions. This may be explained by the different conformational structures of gadA- and gadB-
encoding GADs, though they have similar core structure including PLP-binding sites and active 
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residues (Fig. 1C). This implies that other regional structures of GADs have an impact on their 
activities. Also, LAB GADs exhibit an acidic optimum (pH 4.0 ~ 5.0), which in turn will affect 
the bacterial viability. Hence, mutations to the GADs have been performed via site-directed 
mutagenesis approach in order to improve the enzyme activities under neutral acidic conditions 
(Shi et al., 2014; Yu et al., 2012). Further studies on the improvement of GAD activity via 
mutation under extreme acidic conditions (pH 4.5 ~ 3.5) would be of importance since milk 
fermentation generates an acidic condition in this range. 
PROBIOTIC SPECTRA OF WHOLE CELLS OF LACTOBACILLUS BREVIS IN 
ADDITION TO ITS HIGH GABA BIOSYNTHESIS 
As shown in Table 2, Lb. brevis is an important source of high GABA producers. Hence, its 
probiotic properties would need to be documented before adopting it as functional dairy starter. 
Recently, it was observed that Lb. brevis ATCC 8287 exhibited intestinal immunomodulatory 
effects in piglets (Lahteinen et al., 2014); Lb. brevis OK56 showed anti-obesity property through 
inhibiting the lipopolysaccharides production from gut microbiota, colonic NF-κB signaling 
pathway, and macrophage infiltration into the adipose tissue in mice (Kim et al., 2015); probiotic 
Lb. brevis CD2 inhibited periodontitis via modulatory effects on the host response and the 
periodontal microbiota in mice (Maekawa et al., 2014). Further human subject trail showed a 
reduction in plaque acidogenicity, salivary and bleeding on probing by Lb. brevis CD2 (Campus 
et al., 2014); Lb. brevis KB290 protected mice against influenza virus infection via the long-
lasting enhancement of interferon-α production and the augmentation of IFV-specific IgA 
production (Waki et al., 2014b). A preliminary intervention study conducted on 1089 elementary 
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school children demonstrated that Lb. brevis KB290 was capable of reducing the incidence of 
influenza in school children (Waki et al., 2014a). Moreover, dietary heat-killed Lb. brevis 
SBC8803 could modulate circadian locomotion and sleep rhythms, which might benefit 
individuals with circadian rhythms disrupted by stress or ageing (Miyazaki et al., 2014). In 
addition, polyphosphate, an active molecule derived from Lb. brevis, suppressed intestinal 
inflammation and fibrosis by down regulating the expression of inflammation- and fibrosis-
associated molecules in the intestinal epithelium in murine with colitis (Kashima et al., 2015). 
Although Lb. brevis is involved in spoilage of beer during fermentation (Suzuki et al., 2006), 
based on above recent investigations in terms of its health-promoting effects on the host suggest, 
it is generally accepted as the candidate for probiotics.  
This highlights the possibility of Lb. brevis used as functional starter cultures for dairy 
fermentations or as probiotics for human consumption. However, there are selective criteria for 
the candidate applied as dairy starter including acid production, acidification rate, bacterial 
viability, and proteolytic activity, which shall be clearly demonstrated in dairy fermentations 
before commercialization (Buckenhuskes, 1993).   
TECHNO-FUNCTIONAL PROPERTIES OF LACTOBACILLUS BREVIS 
It is generally recognized that Lb. brevis is a heterofermentative LAB as evidenced by the 
ability to produce lactic acid, acetic acid, ethanol and carbon dioxide as the by-products from 
carbohydrate metabolism. According to the pyruvate metabolism of two complete sequenced Lb. 
brevis strains - ATCC 367 and KB 290 as per Kyoto Encyclopedia of Genes and Genomes 
(KEGG) database, pyruvate is the precursor for the synthesis of lactic and acetic acids, which are 
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the main metabolites that give sour taste to foods. Additionally, carbohydrate metabolism-
generated lactic acid from Lb. brevis could accelerate the gel formation of set-type yogurt during 
fermentation. Moreover, pathways for other metabolites such as acetaldehyde, diacetyl and 
acetoin in above two sequenced strains were also found in KEGG pathway map. These 
compounds synthesized by LAB contribute to the flavor of fermented foods and have been 
detected in various sour milk products (Smit et al., 2005). In addition to the antimicrobial 
property of lactic acid, a novel bacteriocin called “brevicin” from Lb. brevis has been isolated 
and characterized. Brevicin 925A was able to inhibit Listeria monocytogenes and Streptococcus 
mutans (an oral pathogen) (Wada et al., 2009). Brevicin 286 has a narrow inhibition spectrum 
against Listeria sp. (Coventry et al., 1996) and is inhibitory mainly to closely related Lb. brevis 
and Lb. buchneri (Benoit et al., 1997). Brevicin SG1 shows a broad spectrum activity against 
pathogens targeting fungal cell wall and cell membrane (Adebayo et al., 2011). These studies 
highlight that Lb. brevis may be able to produce different types of bacteriocins based on their 
inhibitory spectra against pathogens. This will contribute to the shelf life and safety of fermented 
foods. Above important functional properties and the capability to produce GABA suggests that 
Lb. brevis could be a potential candidate as adjunct starter culture for milk fermentation.  
CHALLENGES FOR MANUFACTURING GABA OR GABA-RICH FERMENTED DAIRY 
FOODS – CONCERNS ON GABA YIELD AND RESIDUAL GLUTAMATE 
Fermented dairy products such as yogurt and cheese have been consumed for thousands of 
years and are still one of the most important sources of diets in modern communities. Based on 
numerous studies, fermented dairy foods can provide protection against cancer, at the mean time 
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some studies also reported that these foods may increase the risk of cancer, although the latter 
claims are inconclusive (Davoodi et al., 2013). Thus the proven health-promoting benefits of 
fermented dairy foods greatly outweigh the unproven harmful effect (Davoodi et al., 2013). 
Studies also suggest that high intake of fermented dairy foods such as yogurt is associated with a 
reduced risk of type 2 diabetes (Chen et al., 2014; O'Connor et al., 2014). Importantly, fermented 
dairy products with probiotics affected the activity of brain regions that regulate the central 
processing of emotional and sensational activities (Tillisch et al., 2013). Moreover, GABA-rich 
fermented milk generated by high GABA-producing LAB could regulate our blood pressure in 
addition to other properties as indicated in Table 1.  
Supplementation of yeast extract, black soybean extract and germinated soybean extract to 
the milk base could improve GABA biosynthesis in GABA producers including Lb. brevis (Ko 
et al., 2013; Nejati et al., 2013; Park et al., 2007b). Those peptides from various extracts provide 
sufficient amino acids to support or trigger the replication and growth of Lb. brevis and other 
GABA producers in the milk environment. Thus, these practices should be taken into account for 
the manufacture of GABA-rich fermented milk. In addition to the nutrient supply, providing 
substrate, glutamate and a co-factor, pyridoxal-5-phosphate (PLP), also accelerate the GABA 
biosynthesis in GABA producers (Shan et al., 2015). However, all of these supplements to milk 
base should be of food-grade level to ensure the safety of end products. There have been only 
few studies pertaining to improving GABA content by using functional GABA producer in 
fermented milk products without supplying extra nutrients. Use of Lb. casei Shirota and Lc. 
lactis YIT 2027 (GABA producer) for milk fermentation without glutamate supplementation 
produced 10-12 mg/100 mL GABA, which exhibited anti-hypertensive effect on mildly 
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hypertensive patients (Inoue et al., 2003). A similar study indicates that milk fermented by Lb. 
helveticus ND01 contained 165.11 mg/kg of GABA in fermented milk in addition to ACE-
inhibitory activity (Sun et al., 2009). Both above studies did not involve the supplementation of 
glutamate as the substrate for producing GABA by GABA-producing LAB. In order to improve 
the GABA yield in fermented milk, three studies reported enhanced GABA yield in milk at 
144.5 mg/kg of milk fermented by Lc. lactis DIBCA2 and Lb. plantarum PU11 (GABA 
producer) with addition of 3.38 g/L monosodium glutamate (MSG) into milk (Nejati et al., 
2013), Lb. plantarum NDC75017 yielded 314.56 mg/100 g of GABA when 80 mM of MSG and 
18 µM of PLP were added to the milk (Shan et al., 2015), and Str. thermophilus YI-B1 and Lb. 
brevis NPS-QW-145 (GABA producer) produced 314.97 mg/kg of GABA in milk containing 2 
g/L of MSG after 24 h fermentation (Wu et al., 2015a). However, MSG was not fully 
metabolized by these starters added to the milk in the above three studies.  
Residual glutamate affect the flavor of the final fermented milk products as glutamate is a 
strong flavoring agent, which has been approved as food additive. This merits further 
investigation on the reduction of its content in these functional fermented milks. At least one 
study suggests that dairy Str. thermophilus could metabolize more MSG than dairy Lb. 
bulgaricus resulting in a reduced MSG content, and co-culture of Str. thermophilus and Lb. 
brevis in milk also showed an improved GABA yield (Wu et al., 2015a). Thus, using high 
GABA producer could be a strategy to generate an enhanced GABA content in fermented dairy 
foods, while Str. thermophilus has the potential to metabolize more glutamate; this still needs to 
be elucidated in the future. 
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ABSENCE OF EXTRACELLULAR PROTEINASES IN THE MAJORITY OF LACTIC 
ACID BACTERIA 
Although Lb. brevis and other novel LAB could be a probiotic candidate as well as a dairy 
starter bacterium, their proteolytic activity needs to be demonstrated at least at genetic level. Cell 
envelope proteinase has been proven to be a key component for maintaining protein metabolism 
and bacterial survival under protein-rich environments (Kunji et al., 1996; Savijoki et al., 2006). 
Firstly, cleavage of large proteins such as milk casein into peptides is achieved by cell envelope 
proteinase, and these peptides are then transported into the bacterial cells via the membrane 
oligopeptide permease, iron-like transporters or ABC transporters for further utilization (Savijoki 
et al., 2006).   
In order to understand the diversity and distribution of cell envelope proteinases in LAB, we 
constructed the phylogenetic tree based on the amino acids sequence of cell envelope proteinases 
and performed a genetic survey regarding to the distribution of cell envelope proteinases as 
shown in Fig. 2.  As shown in Fig. 2C, five types of LAB cell envelope proteinases have been 
classified based on the structure of enzyme domains (Kunji et al., 1996; Savijoki et al., 2006). 
However, it was observed that several LAB species such as Lb. casei (two types; functionally 
distinct) and Lb. helveticus (two types; functionally distinct) possess more than one type of cell 
envelope proteinases, while dairy isolates including Str. thermophilus, Lc. lactis and Lb. 
bulgaricus have only one type of highly conserved cell envelope proteinase (Fig. 2A). As shown 
in the figure, cell envelope proteinase (PrtP) from Lc. lactis shows high identity in amino acids 
sequences with that from Lb. casei. This may suggest that Lb. casei may integrate the gene 
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encoding PrtP from Lc. lactis via HGT events based on the phylogenetic tree (Fig. 2A). This may 
explain the two types of cell envelope proteinases in Lb. casei. 
As shown in Fig. 2B, most completely sequenced LAB strains lack genes encoding cell 
envelope proteinases in their genomes. Attentions should be paid to LAB strains because they 
were selected to be sequenced but were not randomly chosen for sequencing. Due to the cost for 
complete sequencing, there are not many LAB strains that have been completely sequenced. 
However, there are numerous strains sequenced but with different sequencing levels: 1) 
chromosome with gaps; 2) scaffolds; 3) contigs. These incomplete sequencing projects cannot 
provide full genomic information because there were gaps left (unknown fragment sequences). 
However, these strains with complete genomes could be able to provide preliminary information 
because some properties in the same species may be specific and highly conserved. It was found 
that most strains of Lb. casei group including Lb. casei, Lb. paracasei and Lb. rhamnosus may 
have proteolytic activity as evidenced by the presence of genes encoding cell envelope 
proteinases (Fig. 2B). All the four completely sequenced Lb. delbrueckii strains which are 
normally used for milk fermentation possess cell envelope proteinases, while most completely 
sequenced strains of Lc. lactis and Str. thermophilus lack cell envelope proteinases; however, 
genes encoding exported serine proteinase (htrA), which is able to hydrolyze milk proteins, are 
present in the two latter species. Also, genes encoding another typical proteinase – extracellular 
zinc proteinases were observed in most sequenced strains of Lb. plantarum. However, we did not 
identify any extracellular proteinases including cell envelope proteinase, exported serine 
proteinase and extracellular zinc proteinases in the completely sequenced strains of Lb. brevis, 
Lb. reuteri, and Lb. fermentum. It appears that Lb. brevis, the most important high GABA 
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producer, is incapable of hydrolyzing milk proteins, which may lead to failure of milk 
fermentation. 
As mentioned above, Lb. brevis could be used as a functional starter bacterium for its high 
GABA production. However, we observed that one representative isolate, Lb. brevis NPS-QW-
145 (Table 2), a high GABA producer, was not able to ferment milk in the presence of various 
supplemented sugars (Fig. 3). As shown in the figure, additional sugars including glucose, 
galactose and fructose were supplemented to the milk base in addition to its original lactose. To 
our knowledge, glucose is the most common sugar that could be metabolized by bacteria 
including LAB. However, it was observed that this isolate could not significantly acidify milk in 
the presence of various sugars including glucose, galactose, lactose and fructose, whereas the 
viable count of Lb. brevis NPS-QW-145 did not significantly increase after 24 h of fermentation. 
As for the bacterial growth, the carbon source and nitrogen source are the two important factors 
for bacterial replication and metabolic activities. This indicates that Lb. brevis could not break 
down milk proteins (casein) due to its absence of genes-encoding cell envelope proteinases (Wu 
et al., 2015a). In short, Lb. brevis is not able to utilize large peptides as evidenced by the absence 
of cell envelope proteinases in its genome and experimental fermentation results. 
STRATEGIES FOR OVERCOMING THE NON-PROTEOLYTIC NATURE OF 
LACTOBACILLUS BREVIS IN MILK 
In order to apply high GABA-producing Lb. brevis as the functional starter culture for milk 
fermentation, supplementation of small peptides to the milk base could provide sufficient growth 
factors for growing Lb. brevis. Whey, a by-product of cheese making, contains high amount of 
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small peptides, which could be concentrated and used as a source of small peptides (4-20 amino 
acid residues) and supplemented to the milk base as a nitrogen source for Lb. brevis since there 
are various types of peptidases that are encoded in its genomes. 
Another solution is to apply conventional dairy starter that is proteolytic in nature to co-
culture with Lb. brevis during milk fermentation. Since most dairy starters such as Lc. lactis, Str. 
thermophilus and Lb. bulgaricus are capable of breaking down milk casein into peptides; such 
cocktail may produce sufficient peptides and can be further metabolized by the intracellular 
peptidases in Lb. brevis. At least, there is one study that suggests that dairy Str. thermophilus, but 
not dairy Lb. bulgaricus, could be used as a co-culture with Lb. brevis resulting in an enhanced 
viability of Lb. brevis and its GABA biosynthesis in milk (Wu et al., 2015a). It is important to 
examine whether dairy starters compete with Lb. brevis during co-culture. Such selection is 
important before adopting the latter for milk fermentation. 
The third approach is through metabolic engineering for improving proteolytic nature of Lb. 
brevis. This could incorporate the genes-encoding cell envelope proteinase, exported serine 
proteinase or extracellular zinc proteinases into the genome of Lb. brevis, or construct a shuttle 
plasmid which could express above proteinases and transfer it into Lb. brevis for expression. 
This modified Lb. brevis is generally accepted to produce food-grade GABA during fermentation 
using food raw materials. However, this method may not be suggested for manipulating Lb. 
brevis because of its genetically modified status for manufacturing GABA-rich food. One of the 
important concerns is that the selection markers in the plasmids or host genomes during such 
engineering process should not involve the genes encoding antibiotics. If antibiotic genes are 
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used as selection marker in these engineered bacteria, this may increase the risk of antibiotic 
transmission in the gut among people after consumption because the fermented milk is the carrier 
of these bacteria. Thus, it is highly necessary to remove those selection markers in the 
engineered strains. 
CONCLUDING REMARKS & FUTURE TRENDS 
Based on numerous human and animal studies, GABA or GABA-rich foods regulate blood 
pressure and emotion of the host. Due to the low GABA content in natural animal- and plant-
associated food products, high GABA-producing LAB isolates are of great importance to 
produce food-grade GABA and GABA-rich fermented dairy foods via fermentations. Among all 
of GABA producers isolated from various environments, Lb. brevis is an important source of 
GABA-producing microorganism and has been found to exhibit the capability of producing high 
level of GABA. In addition, two functionally distinct GAD-encoding genes (gadA & gadB) and 
one intact gad operon were found in all the sequenced strains of Lb. brevis suggesting its 
common capability of high GABA biosynthesis at both genetic and experimental levels. Thus, 
Lb. brevis could be a functional starter for manufacturing GABA-rich fermented dairy foods. 
However, strategies for the reduction of residual glutamate and enhanced GABA biosynthesis in 
milk by co-culturing Lb. brevis with conventional dairy starters and their interactions need to be 
further demonstrated. In addition, the absence of cell envelope proteinases in Lb. brevis and 
experimental data demonstrate its non-proteolytic nature. Little efforts have been made to 
overcome this shortage. Future studies regarding the improvement of enzymatic activities of 
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GADs in LAB under extreme acidic conditions and improvement of proteolytic activity of Lb. 
brevis merit further investigations. 
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Table 1 Biofunctionalities of GABA-rich foods 
Subject Type of food GABA yield Function(s) Reference(s) 
Mildly hypertensive 
patients 
GABA-rich 
fermented milk 
10 ~ 12 mg/100 
mL 
Blood-pressure-
lowering effect 
(Inoue et al., 
2003) 
Spontaneously 
hypertensive rats 
GABA-enriched 
tempeh-like 
fermented soybean 
1.3 % (w/w) in 
dry powder 
form 
Retarded blood 
pressure 
(Aoki et al., 2003) 
Spontaneously 
hypertensive rats 
GABA-enriched 
soybean 
53.76 mg/g in 
dry powder 
form 
Blood-pressure-
lowering effect 
(Shizuka et al., 
2004) 
Rats with glycerol-
induced acute renal failure 
Pure GABA N.A. Against the renal 
damage involved in 
acute renal failure 
(Kim et al., 2004) 
Streptozotocin-induced 
diabetic rats 
Pure GABA N.A. Impaired glucose 
metabolism; 
enhanced oxidative 
stress 
(Nakagawa et al., 
2005) 
Spontaneously 
hypertensive rats 
GABA-rich soy 
sauce 
1.0 g/100 mL Reduced overall 
cardiovascular risk 
(Yamakoshi et al., 
2007) 
Male Pure GABA N.A. Increased human 
growth hormone 
(Powers et al., 
2008) 
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Human with high-normal 
blood pressure and 
borderline hypertension 
GABA-rich 
Chlorella 
500 mg/100 g in 
the fresh form 
Decreased high-
normal blood 
pressure and 
borderline 
hypertension 
(Shimada et al., 
2009) 
Healthy male GABA-rich 
chocolate 
0.28% (w/w) Psychological stress-
reducing effect 
(Nakamura et al., 
2009) 
Spontaneously 
hypertensive rats 
GABA-rich tomato  179 mg/100 g in 
the fresh form 
Anti-hypertensive 
effect 
(Yoshimura et al., 
2010) 
Forced swimming rat GABA-rich 
Monascus-
fermented product 
16.4 mg/g in dry 
powder form 
Anti-depressant 
effect 
(Chuang et al., 
2011) 
Spontaneously 
hypertensive rats 
GABA-rich 
mulberry leaf 
water extract 
3.8 mg/g in 
water extract 
Anti-hypertensive 
effect 
(Yang et al., 
2012) 
Forced swimming rat GABA-rich 
fermented black 
soybean milk 
5.42 mg/mL Anti-depressant 
effect 
(Ko et al., 2013) 
Streptozotocin-induced 
diabetic rats 
GABA-rich tea 
extract 
1.72 mg/g in the 
dry powder 
form 
Anti-diabetic 
property 
(Cherng et al., 
2014) 
N.A.: not applicable. 
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Table 2 List of representative high GABA-producing lactic acid bacteria and bifidobacteria 
Strain Origin GABA yield Reference 
Lb. brevis NPS-QW-145* Korean kimchi 25.831 g/L (Wu et al., 2015b) 
Lb. brevis NPS-QW-171 Korean kimchi 19.631 g/L (Wu et al., 2015b) 
Lb. brevis NPS-QW-177 Korean kimchi 24.098 g/L (Wu et al., 2015b) 
Lb. brevis NPS-QW-193 Korean kimchi 23.33 g/L (Wu et al., 2015b) 
Lb. brevis NPS-QW-216 Korean kimchi 21.694 g/L (Wu et al., 2015b) 
Lb. brevis NPS-QW-242 Korean kimchi 22.986 g/L (Wu et al., 2015b) 
Lb. brevis NPS-QW-255 Korean kimchi 19.072 g/L (Wu et al., 2015b) 
Lb. brevis NPS-QW-267 Korean kimchi 24.992 g/L (Wu et al., 2015b) 
Lb. brevis NPS-QW-281 Korean kimchi 23.638 g/L (Wu et al., 2015b) 
Lb. brevis NCL912 Chinese paocai 345.83 mM (Li et al., 2010b) 
Lb. brevis IFO-12005 N.M. 10.18 mM (Yokoyama et al., 2002) 
Lb. brevis OPY-1* Korean kimchi 424.67 μg/g (Park et al., 2007b) 
Lb. brevis GABA100 Korean kimchi 26.9 g/L (Kim et al., 2009) 
Lb. brevis BJ20 Fermented Jot-gal 2.465 g/L (Lee et al., 2010) 
Lb. brevis BH2 Korean kimchi 194 mM  (Kim et al., 2007) 
Lb. brevis GABA 057 N.M. 223 mM (Choi et al., 2006) 
Lb. brevis TCCC13007 Pickled vegetables 61 g/L (Zhang et al., 2012) 
Lb. brevis CGMCC 1306 Fresh milk N.M. (Huang et al., 2007) 
Lb. brevis OPK-3 Korean kimchi 84.292 mg/L/h (Park et al., 2007a) 
Lb. brevis DPC6108 Infant feces 16.16 g/L (Barrett, 2014) 
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Lb. brevis FPA 3709 Fish intestine 2.45 g/L (Ko et al., 2013) 
Lb. brevis PM17* Cheese  15 mg/kg (Siragusa et al., 2007) 
Lb. brevis K203 Korean kimchi 44.4 g/L (Binh et al., 2014) 
Lb. brevis 877G* Korean kimchi 22.51 mM (Seo et al., 2013b) 
Lb. brevis CECT 8183 Goat cheese 0.96 mM (Diana et al., 2014) 
Lb. brevis CECT 8181 Sheep cheese 0.94 mM (Diana et al., 2014) 
Lb. brevis CECT 8182 Goat cheese 0.99 mM (Diana et al., 2014) 
Lb. paracasei NFRI 7415 Fermented fish 302 mM (Komatsuzaki et al., 2005) 
Lb. paracasei PF6* Cheese  99.9 mg/kg (Siragusa et al., 2007) 
Lb. plantarum NTU 102 Cabbage pickles 629 mg/L (Tung et al., 2011) 
Lb. plantarum C48* Cheese 16 mg/kg (Siragusa et al., 2007) 
Lb. plantarum DW12 Fermented foods 4 g/L (Ratanaburee et al., 2011) 
Lb. plantarum K154 Korean kimchi 201.78 mg/L (Park et al., 2014b) 
Lb. plantarum NDC75017* Fermented milk 3.15 g/kg (Shan et al., 2015) 
Lb. plantarum NMZ Fermented foods 1.032 mM (Zareian et al., 2012) 
Lb. buchneri MS Korean kimchi 251 mM (Cho et al., 2007) 
Lb. buchneri WPZ001 Fermented sausages 129 g/L (Zhao et al., 2015) 
Lb. sakei B2-16 N.M. 660 mM (Kook et al., 2010) 
Lb. rhamnosus YS9  Pickled vegetables 187 mM (Lin, 2013) 
Lb. bulgaricus PR1* Cheese 63 mg/kg (Siragusa et al., 2007) 
Lb. helveticus ND01 Koumiss 165.11 mg/L (Sun et al., 2009) 
Lb. namurensis NH2  Fermented pork 7.339 g/L (Ratanaburee et al., 2013) 
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Lc. lactis subsp. lactis B Korean kimchi 6.41 g/L (Lu et al., 2008) 
Lc. lactis CECT 8184 Goat cheese 0.93 mM (Diana et al., 2014) 
Lc. lactis PU1* Cheese 36 mg/kg (Siragusa et al., 2007) 
Str. thermophilus Y2 N.M. 7.98 mg/L (Yang et al., 2008b) 
Str. thermophilus ST110* Yogurt starter 655 mg/L (Somkuti et al., 2012) 
Pediococcus pentosaceus 
HN8 
Fermented beef 9.06 g/L (Ratanaburee et al., 2013) 
Pediococcus pentosaceus  
NH102  
Fermented pork 8.386 g/L (Ratanaburee et al., 2013) 
Pediococcus pentosaceus  
NH116  
Fermented pork 8.411 g/L (Ratanaburee et al., 2013) 
Bifidobacterium 
adolescentis DPC6044 
Infant feces 1.57 g/L (Barrett, 2014) 
Bifidobacterium dentium 
DPC6333 
Infant feces 4.31 g/L (Barrett, 2014) 
Bifidobacterium dentium 
NFBC2243 
Infant feces 6.24 g/L (Barrett, 2014) 
Bifidobacterium infantis 
UCC35624 
Infant feces 2.84 g/L (Barrett, 2014) 
Note: GABA yield reported in the reference was associated with cultivation conditions and 
supplemented MSG level. Strains highlighted with asterisk (*) indicated that GABA production 
by this strain has been detected in milk. 
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Table 3 Biochemical properties and kinetics of hetero-expressed and purified GADs from lactic 
acid bacteria 
 
Strain 
GAD 
length (aa) 
Optimal 
conditions 
Enzyme 
kinetics 
Reference(s) 
Lb. brevis IFO 12005 480 pH 4.2, 30℃ Km = 9.3 mM (Uenoa et al., 1997) 
Lc. lactis 01-7 466 pH 4.7, 30℃ Km = 0.5 mM (Nomura et al., 1999b) 
Lb. paracasei NFRI7415 481 pH 5.0, 50℃ Km = 5 mM 
(Komatsuzaki et al., 
2008) 
Str. thermophilus Y2 459 pH 4.0, 55℃ Km = 2.3 mM (Yang et al., 2008a) 
Lb. brevis CGMCC 1306 479 pH 4.8, 48℃ 
Km = 10.26 
mM 
(Fan et al., 2012) 
Lb. brevis 877G 468 pH 5.2, 45℃ Km = 3.6 mM (Seo et al., 2013a) 
Lb. zymae GU240 479 pH 4.5, 41℃ Km = 1.7 mM (Park et al., 2014a) 
Lb. plantarum ATCC 14917 469 pH 4.5, 40℃ Km = 22.8 mM (Shin et al., 2014) 
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Figure 1. Lactobacillus brevis possesses two distinct functionally glutamic acid 
decarboxylases and one intact gad operon. (A) Phylogenetic tree (maximum-likelihood 
method) based on amino acids sequences of glutamic acid decarboxylases from lactic acid 
bacteria and bifidobacteria. (B) Orientation of gad operon and GADs-encoding genes (gadA and 
gadB) in complete genomes of three Lb. brevis strains. (C) Alignment of two representative 
GADs from L. brevis. The catalytic residues were indicated by stars. Figures were generated 
from MEGA (version 6.0) after MUSCLE alignment of GADs. The length of GAD from each 
strain and its GenBank accession numbers are indicated in the braces.  
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Figure 2. Absence of cell envelope proteinases in majority of lactic acid bacteria. (A) 
Phylogenetic tree (maximum-likelihood method) based on amino acids sequences of LAB cell 
envelope proteinase. The figure was generated from MEGA (version 6.0) after MUSCLE 
alignment. The length of proteinase from each LAB strain and the GenBank accession number 
are indicated in the braces; (B) Distribution of cell envelope proteinase(s) in complete sequenced 
lactic acid bacteria; (C) classification of LAB cell envelope proteinases based on the domains of 
certain proteinases (Savijoki et al., 2006; Siezen, 1999). Denotation: PP, pre-pro domain; PR, 
catalytic domain; I, insert domain; A, A domain; B, B domain; H, helix domain; W, cell wall 
spacer domain; white dot, sorting signal; AN, anchor domain. 
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Figure 3. A representative high GABA-producing Lactobacillus brevis NPS-QW-145 could 
not significantly acidify and ferment milk in the presence of lactose, glucose, galactose and 
fructose. Initial bacterial density in 10% (w/v) skimmed milk after inoculation was about 7.81 
Log10 CFU/mL. Conditions for fermentation were at 37℃ for 24 h. Triplicate analysis was 
performed. Data in the figure was presented as mean ± standard deviation. 
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